Ann-christin C. Nickel
Duesseldorf, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma in vivo.
Journal: Frontiers in pharmacology
Published: July 22, 2024
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases.
Journal: Journal of neuro-oncology
Published: January 18, 2024
The development of a hiPSC-based platform to identify tissue-dependencies of IDH1 R132H.
Journal: Cell death discovery
Published: October 14, 2023
In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma.
Journal: Photodiagnosis and photodynamic therapy
Published: June 06, 2022
WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like Cells.
Journal: Cancers
Published: May 12, 2022
Meta-review on Perforation Model of Subarachnoid Hemorrhage in Mice: Filament Material as a Possible Moderator of Mortality.
Journal: Translational stroke research
Published: May 02, 2022
CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells.
Journal: International journal of molecular sciences
Published: April 07, 2022
Progenitor cells derived from gene-engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology.
Journal: Biotechnology journal
Published: December 23, 2021
Current Technologies for RNA-Directed Liquid Diagnostics.
Journal: Cancers
Published: September 15, 2021
Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 16, 2021
Testing the Stability of Drug Resistance on Cryopreserved, Gene-Engineered Human Induced Pluripotent Stem Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 10, 2021
Last Updated: 09/26/2026